Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H 68331-3.

Slides:



Advertisements
Similar presentations
Copyleft Clinical Trial Results. You Must Redistribute Slides PEPCAD II ISR Study Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please.
Advertisements

PCI Unmet Clinical Needs
Comparison of Surgical Treatments for Blocked Arteries By-Pass Surgery with Heart-Lung Machine By-Pass Surgery using Off-Pump Technique Angioplasty with.
W e m a k e i d e a s c o m e a l i v e 001IHP For internal use only Not only a peripheral stent available in Renal sizes...
W e m a k e i d e a s c o m e a l i v e For internal use only Covering all your needs for Fem-Pop Interventions.
ARTS I & II Keith D Dawkins Southampton University Hospital.
Coronary Stent Megan French. What is a Stent A small, mesh-like device made of metal Acts as a support or scaffold, in keeping the vessel open Stent helps.
Rotablation or Balloon Immediate and 6 month results of a trial in patients with chronic total coronary occlusion Layth A. Mimish, M. Bakhshi, J. Buraiki,
Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.
Self-Expanding Stents VS Balloon-Expanding Stents
Θεματική ενότητα: Stenting
2 Introduction Drug-eluting stents have defined a new era in the successful treatment of coronary artery disease However, like any therapy, DES results.
M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.
1 *Report IIB(R) 27/ The CoStar Stent (Conor) was also tested but is not shown in this report as it only presents the commercially available stents.
Angiography By: M.Abid (EE ) Irfan-ullah(EE )
October 8, 2010 Management of Venous Occlusion 2010 Seth J Worley MD Management of Venous Occlusion: Tunneling, Venoplasty and Other Tricks Seth J. Worley.
Cardiac Catheters for Delivery of Cell Suspensions Donald Nick Jensen, DVM, MS Division of Cardiovascular Devices HHS/FDA/CDRH.
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
Confidential: Internal Use only 1 Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level.
Cardiothoracic Surgery. Topics Valvotomy and valve replacement Open heart surgery and cardiac bypass surgery Correction of congenital heart diseases Heart.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Dissolvable Heart Stents Richard Melpignano. Coronary Heart Disease Coronary Heart Disease (CHD) is, as of 2012, the leading cause of death worldwide.
Need Statement and Need Criteria. Need Statement To prevent the reoccurrence of stenosis in coronary arteries. More specifically, to create a solution.
The First Affiliated Hospital of Harbin Medical University
Renal Intervention by the Radial Approach Josef Ludwig, Erlangen Angiosoft.NET.
Featuring Bifurcation Trans-Radial Approach Technical Issues Martial Hamon Caen, France Provisionnal T stenting With the Frontier stent Main Branch Balloon.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
Learning Objectives Drawbacks of traditional POBA
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
Interventional Treatment of obstructive aortoiliac disease Dr Afshin Ghofraniha Interventional Cardiologist.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Treatment of Protected and Unprotected.
Revascularization of the Heart
Open cervical approach for carotid artery stenting
Cardiovascular system
The Endocross Enabler-P: First in-Human Results
PERCUTANEOUS PULMONARY VALVE REPLACEMENT:
Takashi Ashikaga,MD,PhD
Alaa gabi, md sUPERVISOR: RAMEEZ SAYYED, MD.
Bifurcation Balloon & Stent Delivery System
Design & Product Development Larry L Wood
Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.
Direct access of the SFA: step by step
Heavily calcified SFA lesions do not avoid the use of 4 F systems
Guideliner related stent stripping
Clinical Presentation
A Novel “Stent-On-A-Wire”Ultra Low Profile Stent Delivery System
Renal Unit-Careggi University Hospital-Florence-Italy
Crossing SFA-Popliteal Artery CTO’s
A Fixed Guidewire Stent Delivery System
Balloon angioplasty (percutaneous transluminal coronary angioplasty or PTCA)
Renal Unit-Careggi University Hospital-Florence-Italy
SFA Access for TASC D lesions.
DES Bioabsorbable and DCB Technologies
Subintimal Tracking and Reentry for CTO STAR Method
The FDA’s View on CTO-PCI Devices
Regulatory Considerations for Coronary Drug Coated Balloons – FDA View
Catheter-Based Treatment of Coronary Artery Disease
Advances in Interventional Cardiology
Giuseppe Lanzino, MD, Alejandro A. Rabinstein, MD, Robert D. Brown, MD 
Endovascular aortounifemoral grafts and femorofemoral bypass for bilateral limb- threatening ischemia  Takao Ohki, MD, Michael L. Marin, MD, Frank J. Veith,
A Survey on Minimally Invasive Coronary Artery Bypass Grafting
Technique of interventional repair in adult aortic coarctation
Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: An ex vivo analysis  Takao Ohki, MD, Gary S.
Percutaneous revascularization strategies in a patient with previous coronary artery bypass surgery: Technical and patho-physiological insights  Pierfrancesco.
Θεματική ενότητα: Stenting
Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis  William.
Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions.
Recanalization of the occluded basilar artery by percutaneous transluminal angioplasty and stenting. (A) Right ICA angiography revealed that the superior.
Presentation transcript:

Subtitle Text Here Zylon Medical Devices Smaller Is Better Supported by NIH SBIR PHASE II Grant # 5 R44 H

Subtitle Text Here

Overview The Zylon ® Angioplasty catheter with “ZeroFold” Balloon Innovative cardiovascular device Developed to expand clinical application of percutaneous transluminal coronary angioplasty (PTCA) Based on patented technology Angioplasty balloon catheter with “absolutely the lowest profile” Allows certain previously un-crossable or difficult-to-cross stenosed coronary arteries to be crossable and dilatable with efficacy and precision Supported by NIH SBIR Phase II Grant # 5 R44 H

PTCA Percutaneous Transluminal Coronary Angioplasty (PTCA) Minimally invasive surgical approach For treatment of coronary artery blockages Stenosed artery

Current Catheters Current Balloon Catheters As typically used in PTCA procedures Balloon is pre-sized, folded, wrapped and located at end of catheter Catheter is placed across a stenotic lesion Upon presserization, balloon unfolds to force open the stenosis

Crossing the Lesion Physician must be able to cross the lesion to dilate the stenosis Any increase in crossing resistance restricts clinical usefulness, especially in these procedures: Small arteries Tight stenoses Chronic Total Occlusion (CTO)

Surgery Inability to Cross Lesion Consigns patient to open heart surgery Open heart surgery is effective, but characterized by: High morbidity High Expense Long recovery times The Preferred treatment is the minimally invasive balloon angioplasty procedure

The Problem Reducing the profile of the balloon in PTCA catheters still remains clinically significant in interventional cardiology.

The Zylon ® Solution The Zylon ® PTCA Catheter with ZeroFold Balloon Based on patented technology Utilizes a non folded balloon Inflates to full size after crossing target stenosis Eliminates the folded and wrapped balloon of current angioplasty catheters

The Zylon ® Solution Standard Catheter and Balloon Full size balloon attached to catheter shaft Then wrapped and folded to reduce profile Creates region of high cross resistance due to presence of multiple layers of wrapped and folded balloon material

The Zylon ® Solution Zylon ® Catheter with Zero Fold Balloon Balloon has NO wrapped or folded material Exhibits smooth, continuous transition from tip to proximal shaft “Absolutely the lowest profile” possible

The Zylon ® Solution Inflation Zylon ® “ZeroFold” balloons inflate with predictable radial expansion characteristics High burst strength High flexibility Low axial growth

The Zylon ® Solution Zylon ® “ZeroFold” balloon vs. standard folded balloon No Fold Balloon Folded Balloon Inner Lumen

The Zylon Solution Upper Catheter 0.024” Hole Test Fail - at distal fold Zylon Catheter 0.024” Hole Test Pass - entire balloon

The Zylon Solution Other advantages Improved Pushability Easier crossing, less resistance Flexible Smooth gentle inflation Easier to manufacture Simple, no retraining required Smaller* profile over entire range of coronary balloon catheter sizes ( *)

The Zylon Solution Applications CTO Pre-dilation POBA (plain old balloon angioplasty) Stent delivery – lower profile with custom stent Rx, over-the-wire, fixed wire versions

Intellectual Property The following patents and patent applications have relevance to ZeroFold balloon technology: US 5,900,444, Irradiation Conversion of Thermoplastic to Thermoset Polyurethane. US 6,596,818, Irradiation Conversion of Thermoplastic to Thermoset Polymers. US 6,558,732, Process for producing and implantable apparatus comprising a biomedical device coated with cross-linked TPU. US 6,656,550, Dilatation device of uniform outer diameter. EP , Irradiation Conversion of Thermoplastic to Thermoset Polymers. Canada 2,267,684, Irradiation Conversion of Thermoplastic to Thermoset Polymers. IS129342, Irradiation Conversion of Thermoplastic to Thermoset Polymers. US , Process for producing and implantable apparatus comprising a biomedical device coated with cross-linked TPU. US , Irradiation Conversion of Thermoplastic to Thermoset Polymers. US , Reduced Profile Medical Balloon Element.

Intellectual Property Trademarks Zylon, US 2,174,478 Penetrator US Irracure US 2,574,588 Fluorothane US 2,505,088

Subtitle Text Here Zylon Corporation 600 Chestnut Ridge Road Chestnut Ridge, NY Zylon Corporation 600 Chestnut Ridge Road Chestnut Ridge, NY